| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |